Exploratory efficacy of INP104 in patients using concomitant preventive migraine medications

被引：0
|
作者：
Grant, J. [1 ]
Vann, R. [2 ]
Fitzpatrick, C. [2 ]
Lieu, T. [2 ]
Shrewsbury, S. B. [2 ]
Aurora, S. K. [2 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Neurol, Headache & Facial Pain Ctr, New York, NY 10029 USA
[2] Impel NeuroPharma Inc, Seattle, WA USA
来源：
HEADACHE | 2022年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-174
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [21] Assessment of the Potential for Drug-Drug Interactions Between INP104 and Gepants for Migraine Management Using a Model-based Approach
    Ray, S.
    Torphy, B.
    Joshi, S.
    Vann, R.
    Downing, B.
    Murphy, M.
    Fonseca, D.
    Shrewsbury, S.
    Aurora, S.
    HEADACHE, 2023, 63 : 1 - 1
  • [22] Assessment of the Potential for Drug-Drug Interactions Between INP104 and Gepants for Migraine Management Using a Model-based Approach
    Ray, Sutapa
    Torphy, Bradley
    Joshi, Shivang
    Vann, Robert
    Downing, Brett
    Fonseca, Daniella
    Shrewsbury, Stephen
    Aurora, Sheena
    NEUROLOGY, 2023, 100 (17)
  • [23] Prediction of Pharmacokinetics of Repeat Dosing of Dihydroergotamine Mesylate Via Precision Olfactory Delivery (INP104) for the Acute Treatment of Migraine
    Aurora, Sheena
    Robblee, Jennifer
    Mathew, Paul G.
    Vann, Robert E.
    Ray, Sutapa
    Hoekman, John
    CEPHALALGIA, 2023, 43 (1supp) : 218 - 219
  • [24] Improvements in Disability, Migraine Frequency, and the Interictal Period with INP104: Results from the Phase 3 STOP 301 Study
    Armand, Cynthia E.
    Buse, Dawn C.
    Vann, Robert
    Ray, Sutapa
    Shrewsbury, Stephen B.
    Aurora, Sheena K.
    NEUROLOGY, 2022, 98 (18)
  • [25] The use of migraine preventive medications among patients with and without migraine headaches
    Lafata, J. E.
    Tunceli, O.
    Cerghet, M.
    Sharma, K. P.
    Lipton, R. B.
    CEPHALALGIA, 2010, 30 (01) : 97 - 104
  • [26] Real-World Assessment of Baseline Demographic and Clinical Characteristics Among Patients Using INP104 in the United States
    Gokani, T.
    Nguyen, L.
    Vann, R.
    Gutierrez, J.
    Ray, S.
    Aurora, S.
    HEADACHE, 2023, 63 : 157 - 157
  • [27] Do migraine preventive medications enhance the efficacy of triptans? Analyses from topiramate migraine
    Dodick, DW
    Hulihan, J
    Wu, SC
    NEUROLOGY, 2005, 64 (06) : A402 - A402
  • [28] Long-Term Efficacy of Fremanezumab in Patients With Chronic Migraine With Concomitant Preventive Medication Use
    Yeung, Paul
    Goadsby, Peter
    Jann, Adelene
    Cohen, Joshua
    Yang, Ronghua
    Ning, Xiaoping
    NEUROLOGY, 2019, 92 (15)
  • [29] Long-Term Efficacy of Fremanezumab in Patients with Chronic Migraine with Concomitant Preventive Medication Use
    Goadsby, P. J.
    Jann, A. E.
    Cohen, J. M.
    Yang, R.
    Ning, X.
    HEADACHE, 2019, 59 : 117 - 118
  • [30] Concomitant medications and efficacy of nintedanib in patients with IPF
    Kreuter, Michael
    Song, Jin Woo
    Huggins, John T.
    Wallaert, Benoit
    Stansen, Wibke
    Quaresma, Manuel
    Crestani, Bruno
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
12345